199 related articles for article (PubMed ID: 12761360)
1. Analysis of circulating T gamma/delta lymphocytes and CD16/56 cell populations in children and adolescents with Graves' disease.
Bossowski A; Urban M; Stasiak-Barmuta A
Pediatr Res; 2003 Sep; 54(3):425-9. PubMed ID: 12761360
[TBL] [Abstract][Full Text] [Related]
2. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
Bossowski A; Stasiak-Barmuta A; Urban M
Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
[TBL] [Abstract][Full Text] [Related]
3. Expression of very late antigen-4 and lymphocyte function-associated antigen-1 on peripheral blood lymphocytes from patients with graves disease.
Bossowski A; Urban M; Stasiak-Barmuta A; Turowski D
Pediatr Res; 2002 Oct; 52(4):533-7. PubMed ID: 12357047
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
[TBL] [Abstract][Full Text] [Related]
5. Abnormal distribution of gammadelta T lymphocytes in Graves' disease and insulin-dependent diabetes type 1.
Kretowski A; Myśliwiec J; Kinalska I
Arch Immunol Ther Exp (Warsz); 2000; 48(1):39-42. PubMed ID: 10722230
[TBL] [Abstract][Full Text] [Related]
6. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
Bossowski A; Urban M; Stasiak-Barmuta A
J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between OX40/4-1 BB (CD134/CD137) costimulatory molecules expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease].
Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):133-40. PubMed ID: 16232366
[TBL] [Abstract][Full Text] [Related]
8. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
9. Analysis of costimulatory molecules OX40/4-1BB (CD134/CD137) detection on chosen mononuclear cells in children and adolescents with Graves' disease during methimazole therapy.
Bossowski A; Stasiak-Barmuta A; Urban M; Bossowska A
J Pediatr Endocrinol Metab; 2005 Dec; 18(12):1365-72. PubMed ID: 16459462
[TBL] [Abstract][Full Text] [Related]
10. Serial analysis of the effects of methimazole or radical therapy on circulating CD16/56 subpopulations in Graves' disease.
Rojano J; Sasián S; Gavilán I; Aguilar M; Escobar L; Girón JA
Eur J Endocrinol; 1998 Sep; 139(3):314-6. PubMed ID: 9758442
[TBL] [Abstract][Full Text] [Related]
11. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease.
Suzuki Y; Hoshi K; Matsuda T; Mizushima Y
J Rheumatol; 1992 Apr; 19(4):588-92. PubMed ID: 1534375
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
13. Values for αβ and γδ T-lymphocytes and CD4+, CD8+, and CD56+ subsets in healthy adult subjects: assessment by age and gender.
Andreu-Ballester JC; García-Ballesteros C; Benet-Campos C; Amigó V; Almela-Quilis A; Mayans J; Ballester F
Cytometry B Clin Cytom; 2012 Jul; 82(4):238-44. PubMed ID: 22539222
[TBL] [Abstract][Full Text] [Related]
14. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
[TBL] [Abstract][Full Text] [Related]
15. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets.
Paggi A; Amoroso A; Ferri GM; Mariotti A; Pellegrino C; Afeltra A
Eur Rev Med Pharmacol Sci; 1998; 2(1):11-9. PubMed ID: 9825565
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Graves' disease with methimazole in children alters the proliferation of Treg cells and CD3+ T lymphocytes.
Klatka M; Kaszubowska L; Grywalska E; Wasiak M; Szewczyk L; Foerster J; Cyman M; Rolinski J
Folia Histochem Cytobiol; 2014; 52(1):69-77. PubMed ID: 24802963
[TBL] [Abstract][Full Text] [Related]
17. Th17 and Treg cells in adolescents with Graves' disease. Impact of treatment with methimazole on these cell subsets.
Klatka M; Grywalska E; Partyka M; Charytanowicz M; Kiszczak-Bochynska E; Rolinski J
Autoimmunity; 2014 May; 47(3):201-11. PubMed ID: 24443787
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
Cornfield DB; Gheith SM
Cytometry B Clin Cytom; 2009 May; 76(3):213-7. PubMed ID: 18803280
[TBL] [Abstract][Full Text] [Related]
19. The distribution of the major peripheral blood T, B and NK cell subsets does not predict the clinical outcome of Graves' disease patients after methimazole therapy.
Corrales JJ; López A; Ciudad J; Orfao A
J Biol Regul Homeost Agents; 2000; 14(3):193-9. PubMed ID: 11037052
[TBL] [Abstract][Full Text] [Related]
20. [Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results].
Musiał K; Ciszak L; Kosmaczewska A; Szteblich A; Pawlak E; Zwolińska D; Frydecka I
Przegl Lek; 2006; 63 Suppl 3():208-10. PubMed ID: 16898532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
